These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9155667)

  • 1. ACP Broadsheet No 150. March 1997. Antenatal serological testing and prevention of haemolytic disease of the newborn.
    Duguid JK
    J Clin Pathol; 1997 Mar; 50(3):193-6. PubMed ID: 9155667
    [No Abstract]   [Full Text] [Related]  

  • 2. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
    Contreras M
    Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
    [No Abstract]   [Full Text] [Related]  

  • 3. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient.
    Judd WJ; Luban NL; Ness PM; Silberstein LE; Stroup M; Widmann FK
    Transfusion; 1990 Feb; 30(2):175-83. PubMed ID: 2154871
    [No Abstract]   [Full Text] [Related]  

  • 4. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of the BG 15 autoanalyzer for automatic recording and determination of ABO, Rhesus and Kell blood groups].
    Girard M; Michaud C
    Rev Fr Transfus Immunohematol; 1979 Jun; 22(3):265-74. PubMed ID: 115076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of massive fetomaternal hemorrhage presenting without clinical suspicion.
    Pourbabak S; Rund CR; Crookston KP
    Arch Pathol Lab Med; 2004 Apr; 128(4):463-5. PubMed ID: 15043456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 9. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antenatal genotyping of the blood groups of the fetus.
    Avent ND
    Vox Sang; 1998; 74 Suppl 2():365-74. PubMed ID: 9704469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantitation of fetomaternal hemorrhage.
    Turner WA; Fadel HE; Krauss JS
    South Med J; 1986 May; 79(5):571-5. PubMed ID: 3010476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal blood group determination in amniotic cells.
    Vázquez-Escobosa C; Pérez-Medina R; Ramos-Damián ME; Gómez-Estrada H
    Arch Invest Med (Mex); 1982; 13(2):101-4 passim. PubMed ID: 6808946
    [No Abstract]   [Full Text] [Related]  

  • 15. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social.
    Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R
    Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe haemolytic disease of a newborn with variant D mimicking blocked-D phenomenon.
    Das S; Shastry S; Baliga PB
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31843772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When is an anti-D antibody not an anti-D antibody?
    Merron BM; Maguire K; Morris K
    Transfus Med; 2015 Apr; 25(2):115-7. PubMed ID: 25925731
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of ABO haemolytic disease.
    Dunning EK
    Vox Sang; 1968; 14(6):409-16. PubMed ID: 4971967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.